EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bone regeneration using moldable calcium phosphate with and without recombinant human BMP-2 in a rabbit critical-sized metaphyseal core defect model

Hyun Seung Ryu, Hyun Jung Park, Mi Young Ryu, Young-Hoon Kim, Sang-Il Kim, Hyung-Youl Park

Journal of Orthopaedic Surgery and Research · 2025

DOI: 10.1186/s13018-025-05966-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Surgery and Research, 2025. Verfasst von Hyun Seung Ryu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research Center, CGBio Co., Ltd., Seongnam-Si, Gyeonggi-Do, 13211, Republic of Korea. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Bone Regeneration, Calcium Phosphates, Transforming Growth Factor beta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Moldable calcium phosphate (MCaP) biomaterials have been studied as osteoconductive scaffolds for bone regeneration. However, their potential as carriers for recombinant human bone morphogenetic protein-2 (rhBMP-2) and the biological impact of varying rhBMP-2 doses remain to be fully validated. This study aimed to evaluate the efficacy and safety of MCaP alone and in combination with rhBMP-2 in a rabbit metaphyseal bone defect model.

Methods

Bilateral critical-sized metaphyseal core defects were created in the distal femurs of 73 skeletally mature female New Zealand White rabbits. Animals were assigned to six groups: sham, autograft, MCaP alone, or MCaP combined with low (0.04 mg/cc), mid (0.16 mg/cc), or high (0.6 mg/cc) doses of rhBMP-2. Bone formation and healing were assessed at 3 days and 3, 6, and 12 weeks using radiography, microcomputed tomography (μCT), histomorphometry, and histopathology. Local tissue reactions were evaluated according to ISO 10993–6 standards, and systemic toxicity was assessed through distant organ examinations.

Results

Radiographic and μCT analyses showed progressive bone formation in all treatment groups. Compared with autografts, both the MCaP and rhBMP-2-treated groups exhibited significantly higher bone in the region of interest at 6 and 12 weeks ( p < 0.05), with no significant differences between the MCaP-only and rhBMP-2 groups. Histological evaluation revealed earlier and more active bone regeneration in rhBMP-2–treated groups, particularly at higher doses. Minimal inflammatory responses were observed across all groups, and no systemic toxicity was detected, supporting the biocompatibility and safety of MCaP-based constructs.

Conclusions

The MCaP carrier demonstrated strong osteoconductive potential and was sufficient to support bone healing compared to autograft in a metaphyseal defect model. The addition of rhBMP-2 promoted earlier bone formation. However, long-term studies in more challenging bone healing environments are warranted to further assess the clinical utility of rhBMP-2 in bone regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2Bone RegenerationCalcium PhosphatesTransforming Growth Factor betaFemurAnimalsRabbitsRecombinant ProteinsFemaleHumansDisease Models, Animal

Stichwörter der Autor:innen

Bone graft substituteBone regenerationCritical-sized defectMetaphyseal boneMoldable calcium phosphateOsteoconductionRecombinant human bone morphogenetic protein-2 (rhBMP-2)

Substanzen

Bone Morphogenetic Protein 2Calcium PhosphatesRecombinant Proteinsrecombinant human bone morphogenetic protein-2Transforming Growth Factor betacalcium phosphate

Autor:innen und Institutionen

  • Department of Research Center, CGBio Co., Ltd., Seongnam-Si, Gyeonggi-Do, 13211, Republic of Korea.
  • Department of Orthopedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea.
  • Department of Orthopedic Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 1021, Tongil-ro, Eunpyeong-gu, Seoul, 03321, Republic of Korea. matrixbest@naver.com.

Förderung

  • the National Research Foundation of Korea

Zitieren

APA

Ryu, H. S., Park, H. J., Ryu, M. Y., Kim, Y. H., Kim, S. I., & Park, H. Y. (2025). Bone regeneration using moldable calcium phosphate with and without recombinant human BMP-2 in a rabbit critical-sized metaphyseal core defect model. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/s13018-025-05966-y

Vancouver

Ryu HS, Park HJ, Ryu MY, Kim YH, Kim SI, Park HY. Bone regeneration using moldable calcium phosphate with and without recombinant human BMP-2 in a rabbit critical-sized metaphyseal core defect model. Journal of Orthopaedic Surgery and Research. 2025. doi:10.1186/s13018-025-05966-y

BibTeX
@article{Ryu2025,
  author = {Ryu, Hyun Seung and Park, Hyun Jung and Ryu, Mi Young and Kim, Young-Hoon and Kim, Sang-Il and Park, Hyung-Youl},
  title = {Bone regeneration using moldable calcium phosphate with and without recombinant human BMP-2 in a rabbit critical-sized metaphyseal core defect model},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2025},
  doi = {10.1186/s13018-025-05966-y}
}
Kostenlos starten →